Eftsure vs BioCatch
Eftsure
Eftsure is a payment verification platform for finance teams that checks payee and bank details before money leaves the business. It was founded in Sydney in 2014 and has offices in North Sydney, Dallas and Auckland. The platform confirms that a payee is a registered business, checks that the bank account belongs to that payee and screens payees against sanctions lists and government and tax registries. When automated checks cannot resolve a case, Eftsure analysts make out-of-band callbacks. ACH and wire payment files can be reviewed before release, with green and red alerts for matches and mismatches. Eftsure is delivered as a web application, an API or a managed service, and integrates with systems including SAP, Coupa, Workday and Kyriba. It acquired Sis ID in 2025 and announced the acquisition of Relish in September 2026.
Pros
- The Eftsure Guarantee, included in the subscription for customers who signed an agreement after 10 March 2025, covers up to $1 million if a verified payment is lost to social engineering fraud
- Trained fraud analysts investigate and make independent out-of-band callbacks when automated checks cannot resolve a case
- Pre-payment verification is embedded inside Kyriba, FIS Payment Hub and FIS Integrity, as well as SAP, Coupa and Workday
Things to check
- The guarantee covers only social engineering fraud on payments Eftsure has verified, is capped at $1 million, does not state a currency and is subject to Eftsure's terms of service and addendums
- Before go-live Eftsure runs a vendor master file health check (48 hours to 1 week) and verifies anomalies and suppliers not in its database (1 to 3 weeks)
Pricing: Not published; contact sales
BioCatch
BioCatch is a fraud detection platform for banks and other financial institutions. It was founded in 2011, is based in Tel Aviv and has offices in cities including New York, London and São Paulo. As people use digital banking, it collects more than 3,000 anonymised data points, such as keystroke and mouse activity, touch screen behaviour and device signals, and uses machine learning models to tell criminals apart from genuine customers. Its Scams360 product looks for signs of manipulation during a session, such as hesitation, segmented typing or an active phone call, which applies to authorised push payment fraud where the genuine customer makes the transfer. BioCatch Trust lets member banks share risk intelligence on receiving accounts before payment. Permira funds took a majority stake in 2024, and in August 2026 Visa signed an agreement to acquire BioCatch, subject to regulatory approvals.
Pros
- Collects more than 3,000 anonymised data points, including keystroke and mouse activity and touch screen behaviour
- Looks for signs of manipulation even when victims use their own device and credentials, the pattern in authorised push payment scams
- BioCatch Trust flags suspicious receiving accounts to the sending bank in real time before payment execution, with networks in Australia and Argentina
Things to check
- Signal collection needs BioCatch JavaScript on the bank's web pages and its SDKs inside mobile apps
- Ownership is changing: Visa's agreement to acquire BioCatch is subject to regulatory approvals and is expected to close by the end of Visa's fiscal second quarter of 2027
Pricing: Not published; contact sales